US · Healthcare · Medical Instruments & Supplies
EPS came in at 1.01 against a street estimate of 0.93 — a beat of 8.6%.
Analysts rate Merit Medical Systems Inc a buy (9 buy, 2 hold, 0 sell out of 11) with an average price target of $100.67.
CONFIDENT Merit delivered a strong Q3, raised full-year EPS and revenue guidance, and reported broad-based organic growth, though gross margin declined and competition remains intense in Rhapsody. Q3 FY26 U.S. growth was the primary driver of third-quarter revenue performance. Analysts focused on fourth-quarter guidance, Rhapsody adoption and competition, and the SoloPace acquisition strategy. Management emphasized strong underlying momentum while noting China softness and competitive pressure. 2026-10-29…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 15.85% |
| Vanguard Portfolio Management, LLC | 5.82% |
| Vanguard Capital Management, LLC | 4.34% |
| State Street Corp | 4.14% |
| Conestoga Capital Advisors, LLC | 3.32% |
| Geode Capital Management, LLC | 2.72% |
| Fuller & Thaler Asset Management Inc | 2.70% |
| Dimensional Fund Advisors, Inc. | 2.44% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 HEADLINE NUMBERS • For the three months ended September 30, 2026, net sales were $416,244 thousand, up from $384,157 thousand in the same period of 2 | 2026-10-29 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Q3 2026 revenue was $416.2 million, up 8.4% year over year; organic constant-currency revenue increased 9%. • GAAP operating marg | 2026-10-29 |
| Board / officer change · Q3 2026 MERIT MEDICAL SYSTEMS, INC. – FORM 8-K SUMMARY August 14, 2026 --- BUSINESS & SEGMENT HIGHLIGHTS • Merit Medical Systems is a medical device compan | 2026-08-20 |
| Quarterly report · Q2 2026 MERIT MEDICAL SYSTEMS INC – Q2 2026 SUMMARY HEADLINE NUMBERS • Q2 2026 Net Sales: $418.8 million (up 9.5% vs Q2 2025: $382.5 million) • H1 2026 Net | 2026-07-30 |
| Results announced · Q3 2026 MERIT MEDICAL SYSTEMS, INC. – Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 Revenue: $418.8 million, up 10% reported, up 9% constant currency | 2026-07-30 |
| Board / officer change · Q2 2026 MERIT MEDICAL SYSTEMS, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Annual Shareholder Meeting held May 13, 2026 • 59,648,292 total shares entitled to | 2026-05-19 |
| Quarterly report · Q1 2026 MERIT MEDICAL SYSTEMS INC. - Q1 2026 SUMMARY --- HEADLINE NUMBERS • Net sales: $381,877 thousand (Q1 2026) vs. $355,351 thousand (Q1 2025) — increa | 2026-04-30 |
| Results announced · Q2 2026 MERIT MEDICAL SYSTEMS, INC. – Q1 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q1 2026 revenue: $381.9 million, up 7% reported; up 5% constant currency; | 2026-04-30 |
Readable in the app.
| Announcement | Date |
|---|---|
| Company raises full-year 2026 revenue and non-GAAP earnings guidance Merit Medical reported strong third-quarter 2026 results. Revenue was $416.2 million, up 8.4% year over year, including 9% organic growth on a constant-currency basis. Growth was especially | 2026-10-29 |
| Acquired View Point Medical for approximately $140 million in merger transaction Merit Medical Systems acquired View Point Medical, Inc. for approximately $140 million, gaining View Point's OneMark Detection Imaging System, OneMark Tissue Markers, and related assets. The | 2026-04-01 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Merit Medical Systems Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.